DB19131InvestigationalNucleic Acid Based Therapies
Remlarsen is under investigation in clinical trial NCT03601052 (Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids).
- Also known as
- Rna, (am-am-cm-a-cm-um-g-um-um-um-a-cm-a-a-a-um-g-g-um-cm-cm-um-a), 3'-(3-((6-((3.beta.)-cholest-5-en-3-yloxy)hexyl)oxy)-2-hydroxypropyl hydrogen phosphate), complex with rna ((2'-deoxy-2'-fluoro)u-a-g-(2'-deoxy-2'-fluoro)c-a-(2'-deoxy-2'-fluoro)c-(2'-de
- Code names
- MRG-201
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Remlarsen, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account